iX Biopharma Balance Sheet

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	16.49	0.87	1.77	6.52	13.49	6.21
Short-Term Investments	-	0.07	0.07	0.02	0.09	0.01
Cash & Short-Term Investments	16.49	0.94	1.84	6.53	13.59	6.21
Cash Growth	1663.21%	-49.27%	-71.79%	-51.91%	118.65%	8.03%
Accounts Receivable	1.94	1.03	1.29	1.25	0.5	0.22
Other Receivables	-	0.91	1.63	1.8	1.48	1.59
Receivables	1.94	1.94	2.92	3.05	1.98	1.82
Inventory	0.97	0.92	1.38	0.96	0.91	1.1
Prepaid Expenses	-	0.41	0.44	0.44	0.37	0.22
Other Current Assets	0.47	-	-	-	-	-
Total Current Assets	19.87	4.21	6.59	10.98	16.84	9.35
Property, Plant & Equipment	7.09	6.72	7.61	8.22	7.72	8.95
Long-Term Investments	-	-	0.01	3.87	2.26	-
Goodwill	-	0.27	0.29	0.29	0.31	0.33
Other Intangible Assets	0.27	-	0	-	0.04	0.09
Long-Term Deferred Tax Assets	-	-	-	1.38	1.28	-
Other Long-Term Assets	0.14	0.09	0.13	0.19	0.07	0.15
Total Assets	27.36	11.28	14.62	24.93	28.52	18.86
Accounts Payable	3.88	1.3	1.26	0.4	0.22	0.55
Accrued Expenses	0.14	2.99	2.87	2.81	2.31	2.31
Current Portion of Long-Term Debt	4.04	4.08	2.49	2.75	3.29	0.42
Current Portion of Leases	0.36	0.27	0.39	0.44	0.24	0.38
Current Income Taxes Payable	0.19	0.18	0.17	0.73	1.76	-
Other Current Liabilities	-	0.14	0.21	0.05	0.04	0.02
Total Current Liabilities	8.61	8.98	7.38	7.18	7.86	3.67
Long-Term Debt	1.26	1.47	2.18	0.57	0.88	3.2
Long-Term Leases	0.23	0.08	0.14	0.58	-	0.24
Other Long-Term Liabilities	0.25	0.39	0.58	0.76	0.04	0.04
Total Liabilities	10.36	10.92	10.28	9.08	8.77	7.15
Common Stock	122.08	100.83	97.45	97.23	94.18	83.34
Retained Earnings	-109.88	-107.12	-96.98	-86.18	-76.57	-71.97
Comprehensive Income & Other	4.8	6.65	3.87	4.8	2.13	0.34
Shareholders' Equity	17	0.37	4.34	15.85	19.74	11.71
Total Liabilities & Equity	27.36	11.28	14.62	24.93	28.52	18.86
Total Debt	5.9	5.9	5.2	4.34	4.41	4.24
Net Cash (Debt)	10.59	-4.97	-3.36	2.2	9.18	1.98
Net Cash Growth	-	-	-	-76.08%	363.97%	7.91%
Net Cash Per Share	0.01	-0.01	-0.00	0.00	0.01	0.00
Filing Date Shares Outstanding	1,018	887.96	883.34	766.3	764.9	746.17
Total Common Shares Outstanding	1,018	887.96	768.32	766.3	751.19	697.35
Working Capital	11.26	-4.77	-0.8	3.8	8.99	5.68
Book Value Per Share	0.02	0.00	0.01	0.02	0.03	0.02
Tangible Book Value	16.74	0.1	4.05	15.56	19.4	11.3
Tangible Book Value Per Share	0.02	0.00	0.01	0.02	0.03	0.02
Land	-	2.38	2.57	2.56	2.73	2.88
Buildings	-	1.61	1.74	1.74	1.85	1.97
Machinery	-	6.7	6.99	6.71	6.6	7.13
Leasehold Improvements	-	0.71	0.76	0.74	0.64	0.25